돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2181094생성일: 2026년 10월 27일

Acetazolamide → 4-(5-Acetylamino-[1,3,4]thiadiazole-2-sulfonylamino)-3-hydroxy-4-oxo-but-2-enoic acid (4-fluoro-benzyl)-methoxy-amide

https://huagongshe.com/reaction/2181094

반응식

참여 물질

역할이름HCID투입량
반응물AcetazolamideHCID 1986—
반응물2-(2,2-Dimethyl-5-oxo-[1,3]dioxolan-4-ylidene)-N-(4-fluoro-benzyl)-N-methoxy-acetamideHCID 73033233—
생성물4-(5-Acetylamino-[1,3,4]thiadiazole-2-sulfonylamino)-3-hydroxy-4-oxo-but-2-enoic acid (4-fluoro-benzyl)-methoxy-amideHCID 72613069—

반응 단계

2-(2,2-Dimethyl-5-oxo-[1,3]dioxolan-4-ylidene)-N-(4-fluoro-benzyl)-N-methoxy-acetamide was treated with N-(5-sulfamoyl-[1,3,4]thiadiazol-2-yl)-acetamide as described in the preparation of compound 1 to yield the title compound. LCMS (M+H) calcd for C16H17FN5O7S2: 474.1; found: 474.1. 1H NMR (500 MHz, DMSO) δ: 2.21 (s, 3), 3.62 (s, 3), 4.72 (s, 2), 6.32 (s, 1), 6.95 (m, 2), 7.22 (m, 2).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06890942B2
출처 데이터셋uspto-grants-2005_05
ORD IDord-402e2bcb47ea40d492f4e73a0bf7f60b
출처 메모uspto-grants-2005_05